Strong Revenue Growth
EXL generated revenue of $501 million, an increase of 15% year-over-year. Adjusted EPS grew by 27% to $0.48 per share.
Segment Performance
New segments introduced: insurance, healthcare and life sciences, banking, capital markets and diversified industries, and international growth markets. Healthcare and Life Sciences segment reported revenue growth of 24.8% year-over-year.
Data and AI-Led Revenue
Data and AI-led revenue grew 16% year-over-year, representing 53% of total revenue.
Launch of Excelerate.ai
Introduced excelerate.ai, an Agentic AI platform, enabling faster deployment of AI at significantly lower costs.
Strong Sales Pipeline
The sales pipeline remains strong, growing both year-over-year and sequentially in the first quarter.
Financial Strength
Cash including short and long-term investments was $346 million, and the company maintained a net cash position of $39 million.
Raised Revenue Guidance
Increased revenue guidance for 2025 to the range of $2.035 billion to $2.065 billion, representing 11% to 13% growth on a constant currency basis.